• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life.与健康相关生活质量受损相关的是MAFLD而非NAFLD。
J Clin Transl Hepatol. 2022 Feb 28;10(1):4-5. doi: 10.14218/JCTH.2021.00485. Epub 2021 Nov 25.
2
Associations of urinary organophosphate esters metabolites and diet quality with nonalcoholic/metabolic dysfunction-associated fatty liver diseases in adults.尿液有机磷酯代谢物与饮食质量与成年人非酒精/代谢相关脂肪性肝病的关联。
Ecotoxicol Environ Saf. 2023 Apr 1;254:114720. doi: 10.1016/j.ecoenv.2023.114720. Epub 2023 Mar 6.
3
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.代谢相关脂肪性肝病与全因死亡率增加相关在美国。
J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8.
4
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.将非酒精性脂肪性肝病重新命名为代谢相关脂肪性肝病对其患病率、特征及危险因素的影响。
World J Hepatol. 2023 Aug 27;15(8):985-1000. doi: 10.4254/wjh.v15.i8.985.
5
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.代谢功能障碍相关脂肪性肝病与肝细胞癌风险
JHEP Rep. 2023 Jun 28;5(9):100810. doi: 10.1016/j.jhepr.2023.100810. eCollection 2023 Sep.
6
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病与冠状动脉钙化的比较关联：一项横断面和纵向队列研究。
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):482-491. doi: 10.1161/ATVBAHA.122.318661. Epub 2023 Feb 2.
7
NAFLD and MAFLD as emerging causes of HCC: A populational study.非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病作为肝细胞癌的新发病因：一项人群研究。
JHEP Rep. 2021 Jan 19;3(2):100231. doi: 10.1016/j.jhepr.2021.100231. eCollection 2021 Apr.
8
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.代谢相关脂肪性肝病与慢性肾脏病发病风险的关系：一项全国性队列研究。
Diabetes Metab. 2022 Jul;48(4):101344. doi: 10.1016/j.diabet.2022.101344. Epub 2022 Mar 25.
9
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.MAFLD 在健康体检无症状人群中预测心血管疾病风险优于 NAFLD。
Dig Dis Sci. 2022 Oct;67(10):4919-4928. doi: 10.1007/s10620-022-07508-6. Epub 2022 May 17.
10
Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.澳大利亚区域性队列研究中，将非酒精性脂肪性肝病更名为代谢相关性脂肪性肝病的影响：一项前瞻性基于人群的研究结果。
J Gastroenterol Hepatol. 2022 Feb;37(2):395-403. doi: 10.1111/jgh.15723. Epub 2021 Nov 4.

引用本文的文献

1
Metabolic dysfunction-associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病比非酒精性脂肪性肝病表现出更多的肝纤维化。
Medicine (Baltimore). 2025 Feb 7;104(6):e41455. doi: 10.1097/MD.0000000000041455.
2
Exploring the knowledge and attitudes towards metabolic dysfunction associated fatty liver disease (MAFLD): Validation and correlations of MAFLD-knowledge questionnaire and MAFLD-attitude questionnaire.探索对代谢功能障碍相关脂肪性肝病（MAFLD）的认知与态度：MAFLD知识问卷和MAFLD态度问卷的验证及相关性
Heliyon. 2024 Nov 7;10(22):e40217. doi: 10.1016/j.heliyon.2024.e40217. eCollection 2024 Nov 30.
3
Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study.基于代谢相关脂肪性肝病患者的无创性预测nomogram 模型预测显著肝纤维化：一项横断面研究。
Ann Med. 2024 Dec;56(1):2337739. doi: 10.1080/07853890.2024.2337739. Epub 2024 Apr 4.
4
Intragastric Safflower Yellow Alleviates HFD Induced Metabolic Dysfunction-Associated Fatty Liver Disease in Mice through Regulating Gut Microbiota and Liver Endoplasmic Reticulum Stress.胃内红花黄色素通过调节肠道微生物群和肝脏内质网应激缓解 HFD 诱导的代谢功能障碍相关脂肪性肝病。
Nutrients. 2023 Jun 29;15(13):2954. doi: 10.3390/nu15132954.
5
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病的流行病学、自然史及诊断：与非酒精性脂肪性肝病的比较性综述
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139650. doi: 10.1177/20420188221139650. eCollection 2022.
6
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.代谢相关脂肪性肝病：脂肪肝疾病重新定义的两年给我们带来的启示
Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022.

本文引用的文献

1
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study.比较中国人群中MAFLD与NAFLD的诊断标准：一项基于人群的前瞻性队列研究。
J Clin Transl Hepatol. 2022 Feb 28;10(1):6-16. doi: 10.14218/JCTH.2021.00089. Epub 2021 Jul 1.
2
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.定义儿科代谢（功能）相关脂肪性肝病：国际专家共识声明。
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):864-873. doi: 10.1016/S2468-1253(21)00183-7. Epub 2021 Aug 6.
3
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.将脂肪肝纳入代谢性疾病患者的多学科治疗和新型临床试验设计中。
Lancet Gastroenterol Hepatol. 2021 Sep;6(9):743-753. doi: 10.1016/S2468-1253(21)00132-1. Epub 2021 Jul 12.
4
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach.与非酒精性脂肪性肝病相比，代谢功能障碍相关脂肪性肝病能更好地预测动脉粥样硬化性心血管疾病风险的进展：广义估计方程法。
Hepatol Res. 2021 Nov;51(11):1115-1128. doi: 10.1111/hepr.13685. Epub 2021 Jul 2.
5
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.非肥胖 MAFLD 与健康检查受检者的结直肠腺瘤相关：一项多中心回顾性研究。
Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462.
6
The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.撒哈拉以南非洲关于脂肪肝疾病重新定义的立场声明：从非酒精性脂肪性肝病到代谢相关脂肪性肝病
J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20.
7
The NAFLD-MAFLD debate: Eminence vs evidence.非酒精性脂肪性肝病-代谢功能障碍相关脂肪性肝病之争：权威观点与证据较量
Liver Int. 2021 Feb;41(2):255-260. doi: 10.1111/liv.14739. Epub 2020 Dec 2.
8
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.亚太肝病学会代谢相关性脂肪性肝病临床诊疗指南。
Hepatol Int. 2020 Dec;14(6):889-919. doi: 10.1007/s12072-020-10094-2. Epub 2020 Oct 1.
9
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.与非酒精性脂肪性肝病（NAFLD）相比，代谢功能障碍相关脂肪性肝病（MAFLD）能更好地识别出有显著肝纤维化的患者。
Liver Int. 2020 Dec;40(12):3018-3030. doi: 10.1111/liv.14675.
10
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.

MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life.

作者信息

Attia Dina, Aty Nadia Abdel, Shawket Ahmed, Said Ebada, Fouad Yasser

机构信息

Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Beni-Suef University, Egypt.

Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Ain Shams University, Egypt.

出版信息

J Clin Transl Hepatol. 2022 Feb 28;10(1):4-5. doi: 10.14218/JCTH.2021.00485. Epub 2021 Nov 25.

DOI:10.14218/JCTH.2021.00485
PMID:35233367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8845146/
Abstract
摘要